| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |